Medo
AcquiredAI ultrasound assistance for novice users.
What it does
Medo’s FDA-cleared cloud platform segmented ultrasound images into 3D anatomical visuals, delivering clinical insights in seconds. Novice operators could use the AI-driven interface to detect common and critical conditions without specialist training. Medo exited to Exo in 2022.